TSHA logo

Taysha Gene Therapies, Inc. (TSHA) Return On Equity

Annual ROE:

-121.94%+172.10%(+58.53%)
December 31, 2024

Summary

  • As of today, TSHA annual return on equity is -121.94%, with the most recent change of +172.10% (+58.53%) on December 31, 2024.
  • During the last 3 years, TSHA annual ROE has fallen by -21.26% (-21.12%).
  • TSHA annual ROE is now -114.76% below its all-time high of 825.93%, reached on December 31, 2019.

Performance

TSHA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAprofitability metrics

Quarterly ROE:

-73.14%+7.77%(+9.60%)
September 30, 2025

Summary

  • As of today, TSHA quarterly return on equity is -73.14%, with the most recent change of +7.77% (+9.60%) on September 30, 2025.
  • Over the past year, TSHA quarterly ROE has dropped by -32.09% (-78.17%).
  • TSHA quarterly ROE is now -104.30% below its all-time high of 1700.77%, reached on December 31, 2023.

Performance

TSHA Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

TSHA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+58.5%-78.2%
3Y3 Years-21.1%+70.0%
5Y5 Years-114.8%-338.5%

TSHA ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-21.1%+64.6%-104.3%+96.6%
5Y5-Year-114.8%+64.6%-104.3%+96.6%
All-TimeAll-Time-114.8%+64.6%-104.3%+96.6%

TSHA ROE History

DateAnnualQuarterly
Sep 2025
-
-73.14%(+9.6%)
Jun 2025
-
-80.91%(+29.5%)
Mar 2025
-
-114.74%(-2.3%)
Dec 2024
-121.94%(+58.5%)
-112.19%(-173.3%)
Sep 2024
-
-41.05%(+89.1%)
Jun 2024
-
-377.53%(+82.3%)
Mar 2024
-
-2137.00%(-225.6%)
Dec 2023
-294.04%(+14.7%)
1700.77%(+98.2%)
Sep 2023
-
858.17%(-31.1%)
Jun 2023
-
1245.10%(+249.8%)
Mar 2023
-
-831.43%(-90.5%)
Dec 2022
-344.67%
-436.52%(-78.8%)
DateAnnualQuarterly
Sep 2022
-
-244.18%(-32.8%)
Jun 2022
-
-183.88%(-32.7%)
Mar 2022
-
-138.54%(-42.3%)
Dec 2021
-100.68%(-110.7%)
-97.34%(-46.0%)
Sep 2021
-
-66.65%(-45.5%)
Jun 2021
-
-45.81%(-60.0%)
Mar 2021
-
-28.64%(-25.6%)
Dec 2020
-47.79%(-105.8%)
-
Dec 2020
-
-22.81%(-36.8%)
Sep 2020
-
-16.68%(-122.4%)
Jun 2020
-
74.62%
Dec 2019
825.93%
-

FAQ

  • What is Taysha Gene Therapies, Inc. annual return on equity?
  • What is the all-time high annual ROE for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. annual ROE year-on-year change?
  • What is Taysha Gene Therapies, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. quarterly ROE year-on-year change?

What is Taysha Gene Therapies, Inc. annual return on equity?

The current annual ROE of TSHA is -121.94%

What is the all-time high annual ROE for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high annual return on equity is 825.93%

What is Taysha Gene Therapies, Inc. annual ROE year-on-year change?

Over the past year, TSHA annual return on equity has changed by +172.10% (+58.53%)

What is Taysha Gene Therapies, Inc. quarterly return on equity?

The current quarterly ROE of TSHA is -73.14%

What is the all-time high quarterly ROE for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high quarterly return on equity is 1700.77%

What is Taysha Gene Therapies, Inc. quarterly ROE year-on-year change?

Over the past year, TSHA quarterly return on equity has changed by -32.09% (-78.17%)
On this page